Tofacitinib (Xeljanz) May Lower Risk of Colectomy in Severe UC
A recent study has found that using Tofacitinib in addition to traditional IV corticosteroids could help greatly reduce risk of colectomy in hospitalized patients with severe UC. This comes as welcome news, as currently 30% of hospitalized patients with severe UC will not respond to corticosteroids, often making a colectomy the only option. If the … Read more